Chronix Biomedical, Inc. is a US-based molecular diagnostics company developing blood tests for use in cancer treatment and organ transplantation. Chronix's TherasureTM CNI Monitor for cancer uses proprietary algorithms to derive a copy number instability (CNI) score from sequencing of circulating cell-free tumour DNA (cfDNA), which can be used in the prognosis, diagnosis and monitoring of therapeutic response to cancer. Chronix TherasureTM Transplant Monitor quantifies the amount of graft derived cell-free DNA in organ recipients, to detect early rejection of organ transplants and better identify the transplant will be accepted.
Looking for a particular Chronix Biomedical, Inc. employee's phone or email?
Chronix Biomedical, Inc. Questions
The Chronix Biomedical, Inc. annual revenue was $36 million in 2026.
Chronix Biomedical, Inc. is based in San Jose, California.
The NAICS codes for Chronix Biomedical, Inc. are [541, 541711, 54171, 5417, 54].
The SIC codes for Chronix Biomedical, Inc. are [384, 38].
Related Companies
